Iron Toxicity Logo

For U.S. Healthcare Professionals Only

U.S. Patients

Non-U.S. Residents

Iron Overload in Hypotransferrinemia/Atransferrinemia

In hypotransferrinemia/atransferrinemia, impaired transferrin production (or the production of abnormal transferrin) allows non-transferrin-bound iron (NTBI) to be absorbed through the intestine, from where most is deposited in the liver via portal circulation (1,2). Transferrin deficiency may lead to reduced transport of iron to the bone marrow, and therefore impaired erythropoiesis. Iron therefore remains in storage sites such as the liver, leading to iron overload.

How aceruloplasminemia causes iron overload

Print

Disorders of Iron Metabolism

Hypotransferrinemia

Iron and Immune

Compromise

Patients with chronic iron overload may
have increased susceptibility to infections, often
with unusual microorganisms.

Learn more

Contact Us | Site Map | About Novartis Oncology

Novartis Oncology Logo

Use of this website is governed by the Terms of Use and Privacy Policy.

Copyright © 2010 Novartis Pharmaceuticals Corporation. All Rights Reserved.